• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PD-1 blockade in patients with advanced cutaneous squamous-cell carcinoma and concurrent chronic lymphocytic leukaemia : a case series and literature review.

作者信息

Eglmeier Julia, Debus Dirk, Schultz Erwin S

机构信息

Department of Dermatology, Paracelsus Medical University Nuremberg, City Hospital of Nuremberg, Germany.

出版信息

Eur J Dermatol. 2020 Feb 1;30(1):69-71. doi: 10.1684/ejd.2020.3710.

DOI:10.1684/ejd.2020.3710
PMID:32250263
Abstract
摘要

相似文献

1
PD-1 blockade in patients with advanced cutaneous squamous-cell carcinoma and concurrent chronic lymphocytic leukaemia : a case series and literature review.晚期皮肤鳞状细胞癌合并慢性淋巴细胞白血病患者的程序性死亡受体1阻断治疗：病例系列及文献综述
Eur J Dermatol. 2020 Feb 1;30(1):69-71. doi: 10.1684/ejd.2020.3710.
2
Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.不可切除的非转移性原发性黑色素瘤：抗程序性细胞死亡受体1治疗后完全缓解
Acta Derm Venereol. 2019 Jan 1;99(1):107-108. doi: 10.2340/00015555-3028.
3
Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.程序性细胞死亡蛋白1抑制剂治疗皮肤鳞状细胞癌的随访
JAMA Dermatol. 2017 Jan 1;153(1):92-94. doi: 10.1001/jamadermatol.2016.3884.
4
Anti-PD1 in Merkel cell carcinoma and cutaneous squamous cell carcinoma, description of five cases and recent data from the literature.默克尔细胞癌和皮肤鳞状细胞癌中的抗程序性死亡蛋白1（Anti-PD1）：5例病例描述及文献最新数据
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):e159-e161. doi: 10.1111/jdv.15352. Epub 2018 Dec 7.
5
Deceleration in the rate of keratinocyte cancers and precancerous lesions during programmed death-1 inhibition therapy for advanced melanoma, with recrudescence on discontinuation.在晚期黑色素瘤程序性死亡-1抑制治疗期间，角质形成细胞癌和癌前病变的发生率下降，停药后复发。
Clin Exp Dermatol. 2022 Mar;47(3):582-584. doi: 10.1111/ced.14974. Epub 2021 Dec 28.
6
Use of PD-1 (PDCD1) inhibitors for the treatment of Richter syndrome: experience at a single academic centre.使用程序性死亡受体 1（PDCD1）抑制剂治疗 Richter 综合征：单学术中心经验
Br J Haematol. 2019 Apr;185(2):363-366. doi: 10.1111/bjh.15508. Epub 2018 Jul 20.
7
Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma.帕博丽珠单抗联合低分割放射治疗晚期不可切除皮肤鳞状细胞癌。
Eur J Dermatol. 2019 Dec 1;29(6):636-640. doi: 10.1684/ejd.2019.3671.
8
Efficacy of PD-1-based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma.在晚期黑色素瘤的靶向治疗中，影像学进展后 PD-1 免疫治疗的疗效。
Eur J Cancer. 2019 Jul;116:207-215. doi: 10.1016/j.ejca.2019.05.015. Epub 2019 Jun 15.
9
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.III期转移性皮肤鳞状细胞癌对程序性死亡-1抑制剂帕博利珠单抗的反应模式及获得性耐药
Dermatol Ther. 2019 Nov;32(6):e13107. doi: 10.1111/dth.13107. Epub 2019 Oct 21.
10
Killing two birds with one stone: response to pembrolizumab in a patient with metastatic melanoma and B-cell chronic lymphocytic leukaemia.一石二鸟：帕博利珠单抗治疗转移性黑色素瘤合并B细胞慢性淋巴细胞白血病患者的疗效
J Eur Acad Dermatol Venereol. 2018 Feb;32(2):e72-e74. doi: 10.1111/jdv.14537. Epub 2017 Sep 14.

引用本文的文献

1
Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach.皮肤鳞状细胞癌管理建议：一种系统性多学科德尔菲共识方法
Clin Transl Oncol. 2024 Dec 19. doi: 10.1007/s12094-024-03826-5.